Greencamp
FEBRUARY 2, 2019
Even though scientific data is still somewhat scarce on this topic, several studies confirm that cannabis directly acts on the cells of the immune system affected by HIV. It will be the biggest and most comprehensive research on this topic to date, and it will include 400 HIV patients from Florida. 2016 ( 3 ).
Cannabis Law Report
OCTOBER 1, 2021
Epoladerm™ is a topical diclofenac metered-dose spray film formulation being developed to manage acute musculoskeletal pain and osteoarthritis. In 2005, Noble established NobleCon, an investor conference that has grown substantially over the 16 years.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CannaMD
OCTOBER 7, 2019
For instance, in a 2005 review of 297 medical charts, the Journal of Addictive Diseases reported that the rate of cannabis use in the last 12 months was lower in obese subjects than in subjects with a lower BMI. As counterintuitive as it might sound, this conclusion is actually in line with a growing number of studies.
Cannabis Law Report
NOVEMBER 24, 2021
It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). It is unclear whether doctors are feeling completely reassured by laboratory and clinical trial research into medicinal cannabis. Lanham: Rowman & Littlefield Publishers; 2005. Hoffman, T. Google Scholar.
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. Medical Hypotheses (18 aug 2005).
Expert insights. Personalized for you.
110 
Let's personalize your content